000 | 02004 a2200613 4500 | ||
---|---|---|---|
005 | 20250513175731.0 | ||
264 | 0 | _c19990528 | |
008 | 199905s 0 0 eng d | ||
022 | _a1521-6616 | ||
024 | 7 |
_a10.1006/clim.1999.4714 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKishiyama, J L | |
245 | 0 | 0 |
_aA multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. _h[electronic resource] |
260 |
_bClinical immunology (Orlando, Fla.) _cMay 1999 |
||
300 |
_a126-33 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aForced Expiratory Volume |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSteroids |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aValacer, D | |
700 | 1 | _aCunningham-Rundles, C | |
700 | 1 | _aSperber, K | |
700 | 1 | _aRichmond, G W | |
700 | 1 | _aAbramson, S | |
700 | 1 | _aGlovsky, M | |
700 | 1 | _aStiehm, R | |
700 | 1 | _aStocks, J | |
700 | 1 | _aRosenberg, L | |
700 | 1 | _aShames, R S | |
700 | 1 | _aCorn, B | |
700 | 1 | _aShearer, W T | |
700 | 1 | _aBacot, B | |
700 | 1 | _aDiMaio, M | |
700 | 1 | _aTonetta, S | |
700 | 1 | _aAdelman, D C | |
773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 91 _gno. 2 _gp. 126-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/clim.1999.4714 _zAvailable from publisher's website |
999 |
_c10186923 _d10186923 |